Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Dark Pool Levels

CYBN
Cybin Inc.
stock NYSEAMERICAN

At Close
May 8, 2025 3:59:30 PM EDT
6.59USD+6.119%(+0.38)195,687
0.00Bid   0.00Ask   0.00Spread
Pre-market
May 8, 2025 9:19:30 AM EDT
6.30USD+1.449%(+0.09)568
After-hours
May 8, 2025 4:15:30 PM EDT
6.50USD-1.366%(-0.09)1,926
OverviewOption ChainMax PainOptionsPrice & VolumeSplitsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsNews
Jan 31, 2022
07:06PM EST  Magic Mushrooms For Depression: Clinical Trial Of Active Compound Approved For Patients Using Antidepressants   Benzinga
Jan 27, 2022
05:53PM EST  Cybin Announces Additional Adelia Milestone Achievement   Benzinga
07:30AM EST  Cybin to Announce Third Quarter Financial Results and Business Update on February 10, 2022   Business Wire
Jan 18, 2022
07:39AM EST  Psyched: Delix Raises $30M, New Ketamine Study For Alcohol Use Disorder, FDA Approves Ketamine Trial For ALS   Benzinga
Jan 11, 2022
04:44PM EST  Psychedelics Biotech Companies Mark New Milestones In Drug Development Pipelines: Field Trip, Cybin and Wesana   Benzinga
07:31AM EST  Institutional Review Board Grants Approval For Cybin-Sponsored Feasibility Study Using Kernel Flow Technology To Measure Psychedelic Effects On The Brain   Benzinga
Jan 6, 2022
03:46PM EST  Cybin Reports Its Wholly-Controlled Subsidiary Adelia Therapeutics Achieved Milestone   Benzinga
03:45PM EST  Cybin Announces Additional Adelia Milestone Achievement   Business Wire
Dec 30, 2021
09:37AM EST  2021 Was The Year Psychedelics Conquered Capitalism...Or Is It The Other Way Around?   Benzinga
Dec 22, 2021
07:30AM EST  Cybin Provides 2021 Year End Summary   Business Wire
Dec 21, 2021
07:30AM EST  Cybin to Participate in the 11th Annual LifeSci Partners Corporate Access Event and H.C. Wainwright Bioconnect Conference   Business Wire
Dec 15, 2021
07:39AM EST  Cybin Awarded Notice Of Allowance From US Patent And Trademark Office For CYB004 (Deuterated Psychedelic Tryptamine) For The Treatment Of Anxiety Disorders   Benzinga
Dec 9, 2021
09:56PM EST  Psilera's DMT-Derived Drug Sees Positive Results in Pre-Clinical Study   Benzinga
Dec 8, 2021
07:35AM EST  Cybin Confirms Scientific Advice Meeting With UK For Lead Candidate CYB003 For Treatment Of Major Depressive Disorder   RTTNews
07:31AM EST  Cybin Confirms Scientific Advice Meeting With UK Medical And Healthcare Products Regulatory Agency For Q1 2022 For Lead Candidate CYB003 For The Treatment Of Major Depressive Disorder And Alcohol Use Disorder   Benzinga
07:30AM EST  Cybin Confirms Scientific Advice Meeting with UK Medical and Healthcare Products Regulatory Agency for Lead Candidate CYB003 for the Treatment of Major Depressive Disorder and Alcohol Use Disorder   Business Wire
Dec 1, 2021
04:01PM EST  Cybin to Present at the Stifel GMP 2nd Annual Future of Healthcare Conference on December 8, 2021   Business Wire
Nov 30, 2021
05:14PM EST  Psilocybin Trials For COVID-Related Distress Of Healthcare Professionals Could Validate New Psychotherapy Model   Benzinga
04:44PM EST  Cybin Announces FDA Investigational New Drug And Institutional Review Board Approvals For A Co-Funded Phase 2 Clinical Trial To Treat Frontline Clinicians Experiencing COVID-Related Distress   Benzinga
07:39AM EST  Cybin Says FDA Approves Phase 2 Trial To Treat Frontline Clinicians Experiencing COVID-Related Distress   RTTNews
07:30AM EST  Cybin Announces FDA Investigational New Drug and Institutional Review Board Approvals for a Co-Funded Phase 2 Clinical Trial to Treat Frontline Clinicians Experiencing COVID-Related Distress   Business Wire
Nov 29, 2021
04:01PM EST  Cybin to Participate in the H.C. Wainwright 2nd Annual Psychedelics Conference on December 6, 2021   Business Wire
Nov 26, 2021
06:55PM EST  Cybin Announces Additional Adelia Milestone Achievements   Business Wire
Nov 23, 2021
01:01PM EST  NY's Lenox Hill Hospital With Cybin-Awarded Grant Will Provide Psychedelic Therapy To City's Underserved   Benzinga
07:30AM EST  Cybin Awards Grant for Psychedelic Treatment Clinic at Lenox Hill Hospital to Benefit Underserved Communities   Business Wire
Nov 22, 2021
06:25AM EST  HC Wainwright & Co. Maintains Buy on Cybin, Raises Price Target to $10   Benzinga
Nov 19, 2021
10:23AM EST  Cybin Announces Positive Data Showing Effectiveness of Psilocybin To Treat Depression   Benzinga
10:09AM EST  Benzinga's Top Ratings Upgrades, Downgrades For November 19, 2021   Benzinga
08:59AM EST  Maxim Group Downgrades Cybin to Hold   Benzinga
Nov 15, 2021
06:21PM EST  Cybin Reports Q2 Financial Results And Latest News, Including FDA & DEA Research Approvals   Benzinga
06:03PM EST  Cybin Reports Q2 Financial Results And Latest Business Highlights   Benzinga
11:07AM EST  Earnings Scheduled For November 15, 2021   Benzinga
10:40AM EST  Can The Psychedelics Boom Go Bust? A Conversation With Cybin Chief Clinical Officer Dr. Alex Belser   Benzinga
07:30AM EST  Cybin Inc. Reports its Second Quarter Financial Results and Recent Business Highlights   Business Wire
Nov 11, 2021
02:02PM EST  Cybin Unveils Data Suggesting Its Novel Psilocybin Analog Is the 'Superior Molecule'   Benzinga
08:00AM EST  Cybin to Present at the Jefferies London Healthcare Conference   Business Wire
Nov 9, 2021
11:19AM EST  Cybin Announces Positive Data Showing Effectiveness of Psilocybin To Treat Depression   Benzinga
07:00AM EST  Cybin to Announce Second Quarter FY2021 Financial Results and Business Update on November 15, 2021   Business Wire
Nov 8, 2021
10:52AM EST  Psyched: Detroit Decriminalizes Psychedelics, Compass To Study Psilocybin For PTSD, Filaments Gets First-Ever FDA Approval   Benzinga
08:13AM EST  Cybin Reports Positive CYB003 Data Demonstrating Advantages Over Oral Psilocybin For Treatment Of Mental Health   RTTNews
08:07AM EST  Cybin Announces CYB003 Data Demonstrating Significant Advantages Over Oral Psilocybin For Treatment of Mental Health   Benzinga
08:00AM EST  Cybin Announces Positive CYB003 Data Demonstrating Significant Advantages Over Oral Psilocybin for Treatment of Mental Health   Business Wire
Nov 5, 2021
04:12PM EDT  IIROC Trade Resumption - CYBN   PR Newswire
03:35PM EDT  IIROC Trading Halt - CYBN   PR Newswire
09:16AM EDT  Cybin Gets DEA License To Work With Scheduled Psychedelic Molecules   Benzinga
Nov 4, 2021
08:14AM EDT  Cybin Granted DEA Schedule I Manufacturing License   Benzinga
Nov 2, 2021
07:00AM EDT  Cybin Hosting Research and Development Briefing on November 8, 2021   Business Wire
Nov 1, 2021
12:39PM EDT  Psyched: MindMed's MDMA Program For Autism, Small Pharma's New Patent, NovaMentis' Orphan Drug Designation   Benzinga
Oct 28, 2021
07:36AM EDT  Cybin Announces Launch Of EMBARK Psychedelic Facilitator Training Program   Benzinga
Oct 27, 2021
04:10PM EDT  Cybin: FDA Authorizes Feasibility Study To Measure Ketamine's Effect On Cerebral Cortex   Benzinga
Oct 26, 2021
01:49PM EDT  Psyched: British PM Considers Psychedelics, New Partnership To Study Psilocybin For Autism, Compass Gets Another Patent   Benzinga
07:36AM EDT  Cybin Announces FDA IND Authorization Of Cybin's Sponsored Feasibility Study Using Kernel Flow Technology   RTTNews
07:35AM EDT  Cybin Reports FDA Investigational New Drug Authorization Of Co.'s Sponsored Feasibility Study Using Kernel Flow Technology   Benzinga
07:30AM EDT  Cybin Announces FDA Investigational New Drug Authorization of Cybin's Sponsored Feasibility Study Using Kernel Flow Technology   Business Wire
Oct 20, 2021
11:19AM EDT  IIROC Trade Resumption - CYBN   PR Newswire
11:16AM EDT  IIROC Trading Halt - CYBN   PR Newswire
Oct 19, 2021
03:00PM EDT  Psychedelics Discussed At Benzinga Cannabis Capital Conference: Growth Opportunities, Mental Health & Pharma   Benzinga
07:19AM EDT  Cybin Announces Completion Of 74 Pre-Clinical Psychedelic Molecule Studies   Benzinga
Oct 18, 2021
01:37PM EDT  Psyched: The 50 Publicly-listed Psychedelics Companies, Atai's New Subsidiary, PharmaTher Gets New Orphan Drug Designation   Benzinga
08:36AM EDT  KCSA Psychedelics Virtual Investor Conference Presentations Available for   PR Newswire
Oct 13, 2021
04:25PM EDT  There Are Now 50 Psychedelics Companies Listed In The U.S. - Here They Are   Benzinga
Oct 12, 2021
07:11AM EDT  Cybin Files Patent Application Covering Psychedelic Delivery Methods   Benzinga
07:00AM EDT  Cybin Files an International Patent Application Covering Psychedelic Delivery Methods   Business Wire
Oct 7, 2021
02:28PM EDT  'Third California City Moves To Decriminalize Psychedelics As Reform Movement Expands' -Marijuana Moment   Benzinga
07:10AM EDT  Cybin Announces Additional Adelia Milestone Achievements   Benzinga
Oct 5, 2021
10:14AM EDT  Benzinga's Top Ratings Upgrades, Downgrades For October 5, 2021   Benzinga
05:56AM EDT  Oppenheimer Initiates Coverage On Cybin with Outperform Rating, Announces Price Target of $7   Benzinga
Oct 1, 2021
07:00AM EDT  Cybin Announces Appointment of Dr. Amir Inamdar as Chief Medical Officer for European Operations and Dr. Geoff Varty as the Head of Research and Development   Business Wire
Sep 30, 2021
03:16PM EDT  4 Stocks Disrupting Mental Health To Keep An Eye On At Benzinga's Healthcare Conference   Benzinga
12:37PM EDT  From BZ's Small Cap Healthcare Conference: Cybin CEO Doug Drysdale Says Co. Has Deep Pre-Clinical Pipeline Designing Faster Onset, Shorter Duration, Scalable Treatments   Benzinga
12:34PM EDT  From BZ's Small Cap Healthcare Conference: Cybin CEO Doug Drysdale Highlights Partnership With Kernel, Notes Neuroimaging Technology Breakthrough   Benzinga
12:19PM EDT  From BZ's Small Cap Healthcare Conference: Cybin CEO Doug Drysdale Begins Presenting   Benzinga
08:52AM EDT  Four Stocks Disrupting Mental Health To Keep An Eye On At Benzinga's Healthcare Conference   Benzinga
Sep 27, 2021
06:50AM EDT  Cybin to Present at Upcoming Cantor and Benzinga Investor Conferences   Business Wire
Sep 14, 2021
12:54PM EDT  Meet The Top 12 CEOs In The Psychedelics Industry   Benzinga
Sep 9, 2021
04:46PM EDT  Psychedelic Medicine's Top CEOs: Who's Running The Biggest Companies In This Booming Industry?   Benzinga
06:50AM EDT  Cybin to Present at the H.C. Wainwright 23rd Annual Global Investment Conference on September 13th   Business Wire
Sep 3, 2021
12:00PM EDT  'Possessing And Cultivating Psychedelics Would Be Legalized In Michigan Under New Senate Bill' -Marijuana Moment   Benzinga
Sep 1, 2021
09:40AM EDT  IIROC Trading Halt - CYBN   PR Newswire
09:39AM EDT  IIROC Trade Resumption - CYBN   PR Newswire
Aug 31, 2021
05:51PM EDT  Cybin Announces Additional Adelia Milestone Achievements   Business Wire
Aug 30, 2021
11:21AM EDT  Psyched: Cybin Gets $9 Price Target, FSD Pharma Acquires Lucid, New Trials From Psilera, Awakn, PharmaDrug And Braxia, California Bill Put On Hold   Benzinga
Aug 26, 2021
01:09PM EDT  This Psychedelics Stock Could Grow 300% In One Year   Benzinga
10:04AM EDT  Benzinga's Top Ratings Upgrades, Downgrades For August 26, 2021   Benzinga
08:56AM EDT  Cantor Fitzgerald Initiates Coverage On Cybin with Overweight Rating, Announces Price Target of $9   Benzinga
Aug 19, 2021
12:33PM EDT  Cybin Inc. (NEO: CYBN) (NYSE: CYBN) Files Two International Patent Applications In Support Of The Company's Research Phase Programs   Benzinga
07:00AM EDT  Cybin Files Two Additional International Patent Applications in Support of the Company's Research Phase Programs   Business Wire
Aug 17, 2021
07:11AM EDT  Cybin Files Patent Application In Support Of Ongoing Drug Candidate Programs   Benzinga
07:00AM EDT  Cybin Files 14th Patent Application Further Strengthening its IP Portfolio and Receives a Favorable Patent Claim Opinion   Business Wire
Aug 16, 2021
06:29PM EDT  Cybin Announces Election of Theresa Firestone as Director, Results of Shareholders' Meeting and Adoption of Shareholder Rights Plan   Business Wire
Aug 13, 2021
07:00PM EDT  Cybin Inc. Announces 2021 First Quarter Financial Results and Business Highlights   Business Wire
Aug 12, 2021
06:35PM EDT  CORRECTING and REPLACING Cybin Announces Additional Adelia Milestone Achievements   Business Wire
07:00AM EDT  Cybin Announces Additional Adelia Milestone Achievements   Business Wire
Aug 11, 2021
02:56PM EDT  What Do You Really Know About Psychedelics And Psychedelics Stocks?   Benzinga
Aug 10, 2021
08:56AM EDT  Psyched: Cybin Debuts On NYSE, Nonprofits In Psychedelics Space Reach New Milestones, Filament Receives Psilocybin Patent   Benzinga
Aug 9, 2021
07:00AM EDT  Cybin to Present at Canaccord Genuity's 41st Annual Growth Conference on August 10th   Business Wire
Aug 5, 2021
02:51PM EDT  Cybin Becomes First Psychedelics Company On The NYSE: CEO Explains Everything You Need To Know   Benzinga
Jul 28, 2021
09:34AM EDT  Cybin Announces Size and Pricing of Previously Announced Overnight Marketed Public Offering of Common Shares   Business Wire


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC